Strategies in the design of nanoparticles for therapeutic applications

被引:2882
作者
Petros, Robby A. [1 ]
DeSimone, Joseph M. [2 ,3 ,4 ,5 ]
机构
[1] Univ N Texas, Dept Chem, Denton, TX 76203 USA
[2] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[5] N Carolina State Univ, Dept Chem Engn, Raleigh, NC 27695 USA
基金
美国国家科学基金会;
关键词
DRUG-DELIVERY SYSTEMS; B-CELL LYMPHOMA; PHASE-I; TARGETED DELIVERY; INTRACELLULAR TRAFFICKING; CHEMOTHERAPEUTIC-AGENTS; COMPLEMENT ACTIVATION; ALBUMIN MICROSPHERES; CANCER-CHEMOTHERAPY; CONTROLLED-RELEASE;
D O I
10.1038/nrd2591
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Engineered nanoparticles have the potential to revolutionize the diagnosis and treatment of many diseases; for example, by allowing the targeted delivery of a drug to particular subsets of cells. However, so far, such nanoparticles have not proved capable of surmounting all of the biological barriers required to achieve this goal. Nevertheless, advances in nanoparticle engineering, as well as advances in understanding the importance of nanoparticle characteristics such as size, shape and surface properties for biological interactions, are creating new opportunities for the development of nanoparticles for therapeutic applications. This Review focuses on recent progress important for the rational design of such nanoparticles and discusses the challenges to realizing the potential of nanoparticles.
引用
收藏
页码:615 / 627
页数:13
相关论文
共 173 条
[81]   AMPHIPATHIC POLYETHYLENEGLYCOLS EFFECTIVELY PROLONG THE CIRCULATION TIME OF LIPOSOMES [J].
KLIBANOV, AL ;
MARUYAMA, K ;
TORCHILIN, VP ;
HUANG, L .
FEBS LETTERS, 1990, 268 (01) :235-237
[82]   HPMA copolymers: Origins, early developments, present, and future [J].
Kopecek, Jindrich ;
Kopeckova, Pavla .
ADVANCED DRUG DELIVERY REVIEWS, 2010, 62 (02) :122-149
[83]  
Kopf H., 1976, PHARM IND, V38, P281
[84]   ALBUMIN MICROSPHERES AS VEHICLES FOR ACHIEVING SPECIFICITY IN DRUG DELIVERY [J].
KRAMER, PA .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (10) :1646-1647
[85]   PASSAGE OF PEPTIDES THROUGH THE BLOOD-BRAIN-BARRIER WITH COLLOIDAL POLYMER PARTICLES (NANOPARTICLES) [J].
KREUTER, J ;
ALYAUTDIN, RN ;
KHARKEVICH, DA ;
IVANOV, AA .
BRAIN RESEARCH, 1995, 674 (01) :171-174
[86]   Nanoparticles - a historical perspective [J].
Kreuter, Joerg .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 331 (01) :1-10
[87]   Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer [J].
Kukowska-Latallo, JF ;
Candido, KA ;
Cao, ZY ;
Nigavekar, SS ;
Majoros, IJ ;
Thomas, TP ;
Balogh, LP ;
Khan, MK ;
Baker, JR .
CANCER RESEARCH, 2005, 65 (12) :5317-5324
[88]   HPMA copolymers: 30 years of advances Preface [J].
Lammers, Twan ;
Ulbrich, Karel .
ADVANCED DRUG DELIVERY REVIEWS, 2010, 62 (02) :119-121
[89]   A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas [J].
Lee, Cameron C. ;
Gillies, Elizabeth R. ;
Fox, Megan E. ;
Guillaudeu, Steven J. ;
Frechet, Jean M. J. ;
Dy, Edward E. ;
Szoka, Francis C. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (45) :16649-16654
[90]   Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer [J].
Lee, Keun Seok ;
Chung, Hyun Cheol ;
Im, Seock Ah ;
Park, Yeon Hee ;
Kim, Chul Soo ;
Kim, Sung-Bae ;
Rha, Sun Young ;
Lee, Min Young ;
Ro, Jungsil .
BREAST CANCER RESEARCH AND TREATMENT, 2008, 108 (02) :241-250